Hallervorden-Spatz Syndrome and Brain Iron Metabolism
Arch Neurol 48:1285-1293, Swaiman,K.F., 1991
Infantile Neuroaxonal Dystrophy,Clinical Spectrum and Diagnostic Criteria
Neurol 52:1472-1478, Nardocci,N.,et al, 1999
A Man Who Lost Weight and His Sight
Lancet 351:1174-1175, Moschos,M.&Droutsas,D., 1998
Visual System Abnormalities in Adrenomyeloneuropathy
Ann Neurol 37:550-552, Kaplan,P.W.,et al, 1995
Intra-arterial Cisplatin-Associated Optic and Otic Toxicity
Arch Neurol 49:83-86, Maiese,K.,et al, 1992
Lidocaine Unmasks Silent Demyelinative Lesions in Multiple Sclerosis
Neurol 42:2088-2093, Sakurai,M.,et al, 1992
Reversal of a Neurologic Paraneoplastic Syndrome with Octreotide (Sandostatin) in a Pt with Glucagonoma
Am J Med 91:434-436, Holmes,A.,et al, 1991
Vision and Hearing During Deferoxamine Therapy
J Pediatr 117:326-330, Cohen,A.,et al, 1990
Infantile CNS Spongy Degeneration-14 Cases:Clinical Update
Neurol 40:1876-1882, Gascon,G.G.,et al, 1990
Chronic Myelopathies Associated with HTLV-I, A Clinical, Serologic, and Immunovirologic Study of 10 Patients in France
Arch Neurol 46:255-260, Gout,O.,et al, 1989
Cortical Blindness:Etiology, Diagnosis, & Prognosis
Ann Neurol 21:149-158, Aldrich,M.S.,et al, 1987
Visual & Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine Infusions
NEJM 314:869-873, Olivieri,N.F.,et al, 1986
Central Achromatopsia:Behavioral, Anatomic, & Physiologic Aspects
Neurol 30:1064-1071, Damasio,A.,et al, 1980
Clinical Pathological Conference
Adrenoleukodystrophy, with Peripheral Neuropathy, Case Record 18-1979, NEJM 300:1037-104579., , 1979
Chronic Progressive Myelopathy:Investigation with CSF Electrophoresis, Evoked Potentials, & CT Scan
Ann Neurol 6:419-424, Patty,D.W.,et al, 1979
Toluene Optic Neuropathy
Ann Neurol 4:390, Keane,J.R., 1978
"Better Explanations" in Multiple Sclerosis Diagnostic Workup
Neurol 92:e2527-e2537, Calabrese, M.,et al, 2019
Clemastine Fumarate as a Remyelinating Therapy for Multiple Sclerosis (ReBUILD): A Randomised, Controlled, Double-Blind, Crossover Trial
Lancet 390:2481-2489, Green, A.J.,et al, 2017
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-Up of 70 Patients
Arch Neurol 66:841-846, Lebrun,C.,et al, 2009
Early Visual Function Impairment in CADASIL
Neurol 60:2008-2010, Parisi,V.,et al, 2003
Recommended Diagnostic Criteria for Multiple Sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
Ann Neurol 50:121-127, McDonald,W.I.,et al, 2001
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Frequent Involvement of the Optic Radiation in Patients with Acute Isolated Optic Neuritis
Neurol 42:77-79, Hornabrook,R.S.L.,et al, 1992
Symptomatic Retrochiasmal Lesions in MS:Clinical Features, Visual Evoked Potentials, and Magnetic Resonanc Imaging
Neurol 42:68-76, Plant,G.T.,et al, 1992
The Diagnostic Reliability of Magnetically Evoked Motor Potentials In Multiple Sclerosis
Neurol 42:1296-1301, Ravnborg,M.,et al, 1992
Optic Neuritis:A Prospective Study
Neurol 40:919-923, Celesia,G.G.,et al, 1990
Neurosarcoidosis:Signs, Course and Treatment in 35 Confirmed Cases
Medicine 69:261-276, Chapelon,C.,et al, 1990
Cerebrospinal Fluid Immunoglogulins & MS, Correspondence MRI & Visually Evoked Potential Changes
Arch Neurol 46:367-371, Miller,F.A.J.,et al, 1989
MRI in the Diagnosis of MS:Comparison of Clinical Eval, Evoked Potentials, Oligoclonal Banding, & CT
Neurol 38:180-185, 309-3141988., Paty,D.W.,et al, 1988
Evoked Potentials in Chronic Inflammatory Demyelinating Polyneuropathy
Arch Neurol 45:1014-1016, Pakalnis,A.,et al, 1988
Cranial Magnetic Resonance Imaging in the Evaluation of Myelopathy of Undetermined Etiology
Neurol 37:840-843, Miska,R.M.,et al, 1987
Multiple Sclerosis:Magnetic Resonance Imaging, Evoked Responses, & Spinal Fluid Electroporesis
Neurol 36:828-831, Farlow,M.R.,et al, 1986
The Value of Visual Evoked Potential as a Screening Test in Neurofibromatosis
Arch Neurol 42:1072-1074, Jabbari,B.,et al, 1985
New Diagnostic Criteria for Multiple Sclerosis:Guidelines for Research Protocols
Neurol 13:227-231, Poser,C.M.,et al, 1983
Carotid Occlusive Disease, Effect of Bright Light on Visual Evoked Response
Arch Neurol 39:687-689, Donnan,G.A.,et al, 1982
Clin. Path. Conference
Osteopetrosis, Malignant Juvenile Form, Case Record 37-1982, NEJM 307:735-74382., , 1982
Visual Evoked Potentials in Occipital Lobe Lesions
Arch Neurol 38:80-85, Streletz,L.J.,et al, 1981
Leber's Optic Neuropathy
Editorial, BMJ 280:1097-10981980., , 1980
Visual Function of the Extrageniculo-calcarine System in Man
Arch Neurol 37:704-706, Celesia,G.G.,et al, 1980
Visual Evoked Potentials in the Evaluation of"Cortical Blindness"in Children
Ann Neurol 6:126-129, Frank,Y.,et al, 1979
Visual Electroencephalographic Computer Analysis (VECA) :A New Electrophysiologic Test for the Diagnosis of Optic Lesions
Neurol 27:637, Celesia,G.G.,et al, 1977
Subclinical Optic Neuropathy in Multiple Sclerosis
Arch Neurol 34:666, Galvin,R.J.,et al, 1977